Merit Medical Systems Inc. (NASDAQ:MMSI) director, Millner F. Ann, has recently engaged in significant stock transactions, according to the latest SEC filings. On June 28, 2024, Ann sold a total of 12,500 shares of the company's common stock at an average price of $85.00 per share, resulting in a total value of $1,062,500. These transactions were carried out under a pre-arranged trading plan.
The director's trading activity did not stop at selling shares; the same filings also report the acquisition of 12,500 shares at a price of $50.50 each, amounting to a purchase total of $631,250. It is important to note that the reported sales and purchases reflect a planned trading strategy, as indicated by a footnote in the SEC filing, stating that the transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Ann on August 7, 2023.
Following these transactions, Millner F. Ann's direct ownership in the company has been adjusted to 32,391 shares of common stock. These recent trades by a high-ranking insider are likely to be of interest to current and potential investors, as insider activity can provide insights into the company's performance and outlook.
For those unfamiliar with the company, Merit Medical Systems Inc. specializes in manufacturing and marketing medical devices, primarily for use in cardiology, radiology, and endoscopy procedures. The company has established itself as a player in the surgical and medical instruments sector, with a commitment to innovation and patient care.
Investors and analysts often monitor insider trading patterns for signs of corporate insiders' confidence in the company's future prospects. With the information provided by the SEC filings, market participants can gain a better understanding of the internal perspectives within Merit Medical Systems Inc.
In other recent news, Merit Medical Systems has seen significant developments. The healthcare technology company recently acquired assets from EndoGastric Solutions, a move that is expected to add approximately $30 million in annualized revenue and broaden Merit's endoscopy offerings. This acquisition is projected to contribute between $13 million and $15 million in sales for the remainder of 2024.
The company also reported a 9.3% increase in revenue to $324 million and earnings per share of $0.77 in the first quarter, surpassing analysts' expectations. Its updated financial guidance for 2024 now includes net sales of $1.324 to $1.340 billion and non-GAAP earnings per share of $3.22 to $3.31.
In terms of analyst ratings, Canaccord Genuity maintained a Buy rating on Merit Medical's stock and increased its price target to $125, while Piper Sandler and Wells Fargo maintained their Overweight and Equal Weight ratings, respectively. The company also welcomed Silvia M. Perez to its board of directors, adding her extensive healthcare industry experience to the team.
Finally, Merit Medical received FDA clearance for its Siege Vascular Plug and launched its Bearing nsPVA Express Prefilled Syringe in the United States and Australia, further strengthening its Embolics portfolio. These are all recent developments that highlight Merit Medical's ongoing growth and strategic direction.
InvestingPro Insights
Merit Medical Systems Inc. (NASDAQ:MMSI) has been showcasing some noteworthy financial metrics that could be of interest to investors following the recent insider trading activity by director Millner F. Ann. Here's a closer look at the company's financial health and market performance based on real-time data from InvestingPro.
InvestingPro Data shows that Merit Medical Systems has a market capitalization of $5.02B, with a high P/E ratio of 48.26 as of the last twelve months ending Q1 2024. The company's revenue growth for the same period stands at a solid 9.39%, indicating a steady upward trajectory in its financial performance.
Additionally, the firm's stock has been trading near its 52-week high, at 99.4% of the peak value, underscoring a strong return over the last three months with an 18.47% price total return. This could signal investor confidence and a positive market sentiment towards the company's stock.
Two InvestingPro Tips that stand out for Merit Medical Systems include the expectation of net income growth this year and the company's ability to maintain a moderate level of debt. These insights suggest that investors might look forward to a potentially profitable year ahead for Merit Medical Systems, supported by prudent financial management.
For those interested in exploring more about Merit Medical Systems' financial outlook, InvestingPro offers additional tips that could be valuable in making informed investment decisions. There are 13 more InvestingPro Tips available for Merit Medical Systems at https://www.investing.com/pro/MMSI, which provide a deeper dive into the company's valuation, profitability, and stock performance.
Remember, by using the coupon code PRONEWS24, readers can get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, unlocking further insights that could enhance investment strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.